Literature DB >> 19436119

IVIG reduced vascular oxidative stress in patients with Kawasaki disease.

Shinichi Takatsuki1, Yuka Ito, Daiji Takeuchi, Hiroshi Hoshida, Tomotaka Nakayama, Hiroyuki Matsuura, Tsutomu Saji.   

Abstract

BACKGROUND: Oxidative stress (OS) contributes to the acute phase of Kawasaki disease (KD) in a manner that is as yet unknown. In the present study OS in the acute phase of KD was investigated by measuring urinary 8-iso-prostaglandin F2alpha (8-iso-PG) and evaluating its correlation to the efficacy of intravenous immunoglobulin (IVIG) administration. METHODS AND
RESULTS: The 62 patients with acute phase of KD were enrolled, as well as 20 healthy children (HC) and 20 with acute febrile illness (FI). Urinary samples were obtained before and after administration of IVIG. The HC and FI groups also had inflammatory markers evaluated at the same time. The 8-iso-PG was significantly elevated in the 62 KD patients (719 +/-335 pg/mg Cr) without IVIG administration compared with those with FI (583 +/-213 pg/mg Cr) as well as HC (443 +/-288 pg/mg Cr) (P<0.01). 40 patients were given 3 different regimens of IVIG: 16 received 2 g/kg for 1 day; 17 received 1 g/kg for 1 day; 7 received 400 mg . kg(-1) . day(-1) for 5 days. All regimens of IVIG reduced the 8-iso-PG level at 7 days after initiation.
CONCLUSIONS: OS provokes vasculitis in KD, the activation of which was reduced by IVIG. The urinary level of 8-iso-PG is a useful marker of the effectiveness of IVIG in the acute phase of KD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19436119     DOI: 10.1253/circj.cj-07-0635

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  6 in total

1.  Coding single-nucleotide polymorphisms of interleukin-1 gene cluster are not associated with Kawasaki disease in the Korean population.

Authors:  Su Kang Kim; Sung Wook Kang; Joo-Ho Chung; Jong Seok Lee; Hyun Kyung Park; Kyung Lim Yoon; Soo Cheol Kim
Journal:  Pediatr Cardiol       Date:  2011-01-30       Impact factor: 1.655

2.  Regulation of oxidative stress in patients with Kawasaki disease.

Authors:  Kaori Sekine; Hiroyuki Mochizuki; Yoshinari Inoue; Tohru Kobayashi; Eisuke Suganuma; Shinichi Matsuda; Hirokazu Arakawa
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

3.  Intravenous immunoglobulin counteracts oxidative stress in Kawasaki disease.

Authors:  Kazunari Kaneko; Masaya Takahashi; Ken Yoshimura; Tetsuya Kitao; Sohsaku Yamanouchi; Takahisa Kimata; Shoji Tsuji
Journal:  Pediatr Cardiol       Date:  2012-02-11       Impact factor: 1.655

4.  Hydrogen Gas Inhalation Regressed Coronary Artery Aneurysm in Kawasaki Disease-Case Report and Article Review.

Authors:  Ho-Chang Kuo
Journal:  Front Cardiovasc Med       Date:  2022-05-12

5.  Anti-inflammatory effect of resveratrol in human coronary arterial endothelial cells via induction of autophagy: implication for the treatment of Kawasaki disease.

Authors:  Fu-Chen Huang; Ho-Chang Kuo; Ying-Hsien Huang; Hong-Ren Yu; Sung-Chou Li; Hsing-Chun Kuo
Journal:  BMC Pharmacol Toxicol       Date:  2017-01-09       Impact factor: 2.483

Review 6.  Kawasaki disease: aetiopathogenesis and therapeutic utility of intravenous immunoglobulin.

Authors:  Caroline Galeotti; Jagedeesh Bayry; Isabelle Kone-Paut; Srinivas V Kaveri
Journal:  Autoimmun Rev       Date:  2010-01-13       Impact factor: 9.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.